Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 138Terminated 28Active not recruiting 10Withdrawn 9Unknown 4Recruiting 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × temsirolimus × Clear all
NCT03571438 2020-01-18

COMBOREIN

University Hospital, Grenoble

Phase NA Unknown
100 enrolled
Genitourinary

Kidney Neoplasms

NCT01653067 2016-10-27

STORM

University Hospital Heidelberg

Phase 2 Unknown
88 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT01567930 2012-12-17

Temsirolimus as Second-line Therapy in HCC

University of Tennessee Cancer Institute

Phase 2 Unknown
25 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01246817 2012-04-11

Temsirolimus-RCC-imaging

Radboud University Medical Center

Phase 2 Unknown
51 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡